The Rome IV criteria are a standardized set of symptom-based guidelines used to diagnose functional gastrointestinal (GI) disorders, conditions where the digestive tract doesn’t work properly but no structural or biochemical cause can be found on standard tests. Published in 2016 by the Rome Foundation, they replaced the earlier Rome III criteria and cover more than 30 distinct disorders affecting every part of the digestive system, from the esophagus to the rectum. If you’ve been told you have irritable bowel syndrome, functional dyspepsia, or functional heartburn, there’s a good chance Rome IV criteria played a role in that diagnosis.
Why Symptom-Based Criteria Exist
Functional GI disorders are genuinely common, but they don’t show up on blood tests, imaging, or biopsies. An endoscopy looks normal. Lab work comes back clean. Yet the symptoms, including pain, bloating, nausea, and irregular bowel habits, are real and often disruptive. Before the Rome criteria existed, these patients were frequently dismissed or given vague labels like “nervous stomach.” The Rome system gives clinicians a consistent framework: if a patient’s symptoms match a specific pattern for a specific duration, a positive diagnosis can be made without exhaustive (and expensive) testing.
This is a key philosophical shift. Rather than diagnosing functional disorders only after every other possibility has been ruled out, Rome IV encourages clinicians to recognize characteristic symptom patterns and make a confident diagnosis early. Routine investigations are still recommended to check for obvious structural problems, but the criteria are designed to stand on their own rather than serve as a last resort.
How the Timeline Requirements Work
Nearly all Rome IV diagnoses share a common time threshold: symptoms must have been present for the last 3 months, and they must have first started at least 6 months before the diagnosis is made. This two-part requirement filters out short-lived problems. A few weeks of stomach trouble after a bout of food poisoning wouldn’t qualify. The criteria are looking for a chronic, recurring pattern that has established itself over half a year or more.
Within that 3-month active window, each specific disorder has its own frequency requirement. Some conditions require symptoms on most days; others only need symptoms one day per week. These frequency cutoffs help distinguish between occasional discomfort that most people experience and a genuine disorder affecting daily life.
Irritable Bowel Syndrome Under Rome IV
IBS is probably the most well-known condition diagnosed with Rome IV criteria. The definition centers on recurrent abdominal pain occurring at least one day per week during the most recent 3 months. That pain must be related to bowel movements in at least one of three ways: it’s connected to defecation (either triggered by it or relieved by it), it’s associated with a change in how often you go, or it’s associated with a change in the appearance or consistency of your stool.
Earlier versions of the Rome criteria used the word “discomfort” alongside “pain,” which created ambiguity. Rome IV dropped that term entirely, making abdominal pain the central requirement. The frequency threshold also increased. Under Rome III, symptoms needed to be present at least 3 days per month. Rome IV raised the bar to at least 1 day per week, which translates to roughly 4 days per month. This tightened the diagnostic boundary to focus on people whose symptoms are frequent enough to meaningfully affect their quality of life.
IBS is further categorized into subtypes based on stool consistency: IBS with constipation, IBS with diarrhea, IBS with mixed bowel habits, and unclassified IBS. These subtypes guide treatment decisions, since the management approach differs depending on whether the primary problem is loose stools, hard stools, or an unpredictable combination.
Functional Dyspepsia: Two Distinct Subtypes
Functional dyspepsia, sometimes called chronic indigestion with no identifiable cause, is split into two subtypes under Rome IV. Each has its own criteria, and some patients meet both.
Postprandial Distress Syndrome (PDS) focuses on meal-related symptoms. To qualify, you need to experience at least one of the following on 3 or more days per week: fullness after eating that is severe enough to interfere with your usual activities, or feeling full so quickly during a meal that you can’t finish a regular-sized portion. These aren’t mild inconveniences. The criteria specify that symptoms must be “bothersome,” meaning they genuinely disrupt your routine.
Epigastric Pain Syndrome (EPS) centers on pain or burning in the upper abdomen, in the area below the breastbone and above the navel. The threshold is lower: symptoms need to occur at least 1 day per week. Again, the pain or burning must be severe enough to affect daily activities. Unlike PDS, EPS symptoms don’t necessarily relate to meals.
For both subtypes, there must be no evidence of a structural or metabolic disease that could explain the symptoms. This typically means an upper endoscopy has been performed and came back normal. The same 3-month active and 6-month onset timeline applies.
Functional Esophageal Disorders
Rome IV also covers conditions affecting the esophagus, the tube connecting your throat to your stomach. Functional heartburn is one example. It’s diagnosed when a person experiences a burning sensation behind the breastbone, but endoscopy shows no damage and testing reveals normal acid levels in the esophagus. In other words, the tissue looks healthy and acid exposure is within normal range, yet the symptom persists.
This is where the criteria get particularly nuanced. A person with heartburn and a normal endoscopy could have one of three conditions. If acid exposure testing shows abnormally high acid levels, they likely have a form of reflux disease (NERD, or non-erosive reflux disease). If acid exposure is normal but there’s a clear, measurable link between individual reflux episodes and the onset of symptoms, the diagnosis is reflux hypersensitivity. Only when acid exposure is normal and the heartburn has no correlation to reflux events at all does the diagnosis become functional heartburn. Rome IV drew these distinctions for the first time, which was a significant advance over earlier versions.
How Common These Conditions Are
Functional GI disorders diagnosed by Rome IV criteria are remarkably prevalent. Studies using these criteria in pediatric populations found that about 25% of infants and toddlers (ages 0 to 3) and 25% of children and adolescents (ages 4 to 18) met symptom-based criteria for at least one functional GI disorder. Among infants, the most common issue was regurgitation, affecting about 24% of that age group. Among toddlers, functional constipation was the leading diagnosis at 18.5%, and it remained the most common disorder in older children at 14.1%.
In adults, estimates vary by population and study method, but functional GI disorders collectively affect roughly 40% of people worldwide at some point. IBS alone is thought to affect around 4 to 5% of the global population under the stricter Rome IV definitions, down from higher estimates under Rome III, largely because Rome IV raised the symptom frequency thresholds.
What Changed From Rome III to Rome IV
Rome IV wasn’t a minor update. The 2016 revision reflected a broader shift in how functional GI disorders are understood. The older term “functional” was maintained but reframed: these conditions are now viewed as disorders of gut-brain interaction, a label that acknowledges the complex communication between the central nervous system and the digestive tract. Abnormal nerve signaling, altered gut motility, changes in the gut’s microbial environment, and heightened sensitivity in the intestinal lining all play roles.
Beyond the conceptual shift, several practical changes stand out. The removal of “discomfort” from IBS criteria sharpened the definition. The introduction of reflux hypersensitivity as a separate esophageal disorder improved diagnostic precision. Frequency thresholds were recalibrated across multiple conditions. And the criteria placed new emphasis on symptoms being “bothersome” rather than merely present, ensuring that diagnoses capture conditions severe enough to warrant clinical attention rather than normal digestive variation.
What the Criteria Mean for Patients
If your doctor mentions Rome IV criteria during an evaluation, it means they’re using a widely accepted, evidence-based framework rather than guessing. A diagnosis made through these criteria is considered a positive identification, not a placeholder for “we don’t know what’s wrong.” This matters because it opens the door to targeted treatments, including dietary changes, medications that address gut-brain signaling, psychological therapies like cognitive behavioral therapy, and other approaches that have been validated specifically for these conditions.
It also means the diagnosis has built-in specificity. You aren’t just told you have “a sensitive stomach.” You’re given a defined condition with established criteria that other clinicians worldwide would recognize and apply the same way. That consistency is what makes the Rome system valuable, both for the clinician making treatment decisions and for the patient trying to understand what’s happening in their body.